Correlation Between Opthea and Seelos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Opthea and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opthea and Seelos Therapeutics, you can compare the effects of market volatilities on Opthea and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Seelos Therapeutics.

Diversification Opportunities for Opthea and Seelos Therapeutics

0.35

Correlation Coefficient

Opthea  Seelos Therapeutics

Weak diversification

The 3 months correlation between Opthea and Seelos is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of Opthea i.e., Opthea and Seelos Therapeutics go up and down completely randomly.

Pair Corralation between Opthea and Seelos Therapeutics

Considering the 90-day investment horizon Opthea is expected to generate 0.29 times more return on investment than Seelos Therapeutics. However, Opthea is 3.4 times less risky than Seelos Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.24 per unit of risk. If you would invest  341.00  in Opthea on September 17, 2024 and sell it today you would lose (7.00) from holding Opthea or give up 2.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	70.77%
Values	Daily Returns

Opthea  vs.  Seelos Therapeutics

Opthea

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Opthea is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Seelos Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Seelos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with Opthea and Seelos Therapeutics

The main advantage of trading using opposite Opthea and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.

The idea behind Opthea and Seelos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.